{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:34:01Z","timestamp":1762101241399},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T00:00:00Z","timestamp":1321315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12016-011-8286-7","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T06:14:06Z","timestamp":1321251246000},"page":"16-25","source":"Crossref","is-referenced-by-count":11,"title":["Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders"],"prefix":"10.1007","volume":"42","author":[{"given":"Minoru","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward K. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,15]]},"reference":[{"key":"8286_CR1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tig.2008.05.004","volume":"24","author":"KE Lukong","year":"2008","unstructured":"Lukong KE, Chang KW, Khandjian EW, Richard S (2008) RNA-binding proteins in human genetic disease. Trends Genet 24:416\u2013425","journal-title":"Trends Genet"},{"key":"8286_CR2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1017\/S1462399410001523","volume":"12","author":"D Baumer","year":"2010","unstructured":"Baumer D, Ansorge O, Almeida M, Talbot K (2010) The role of RNA processing in the pathogenesis of motor neuron degeneration. Expert Rev Mol Med 12:e21","journal-title":"Expert Rev Mol Med"},{"key":"8286_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21428","volume":"41","author":"SJ Kolb","year":"2010","unstructured":"Kolb SJ, Sutton S, Schoenberg DR (2010) RNA processing defects associated with diseases of the motor neuron. Muscle Nerve 41:5\u201317","journal-title":"Muscle Nerve"},{"key":"8286_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"8286_CR5","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15:3555\u20133565","journal-title":"EMBO J"},{"key":"8286_CR6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","volume":"298","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni L, Yong J, Dreyfuss G (2002) Essential role for the SMN complex in the specificity of snRNP assembly. Science 298:1775\u20131779","journal-title":"Science"},{"key":"8286_CR7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ceb.2009.02.004","volume":"21","author":"A Chari","year":"2009","unstructured":"Chari A, Paknia E, Fischer U (2009) The role of RNP biogenesis in spinal muscular atrophy. Curr Opin Cell Biol 21:387\u2013393","journal-title":"Curr Opin Cell Biol"},{"key":"8286_CR8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE (2009) Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 10:597\u2013609","journal-title":"Nat Rev Neurosci"},{"key":"8286_CR9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","volume":"44","author":"EM Tan","year":"1989","unstructured":"Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93\u2013151","journal-title":"Adv Immunol"},{"key":"8286_CR10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1586\/1744666X.3.5.721","volume":"3","author":"M Satoh","year":"2007","unstructured":"Satoh M, Chan EKL, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH (2007) Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 3:721\u2013738","journal-title":"Expert Rev Clin Immunol"},{"key":"8286_CR11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/art.30349","volume":"63","author":"M Satoh","year":"2011","unstructured":"Satoh M, Chan JY, Ross SJ, Ceribelli A, Cavazzana I, Franceschini F, Li Y, Reeves WH, Sobel ES, Chan EK (2011) Autoantibodies to survival of motor neuron (SMN) complex in patients with polymyositis\u2014immunoprecipitation of D-E-F-G without other components of small nuclear ribonucleoproteins. Arthritis Rheum 63:1972\u20131978","journal-title":"Arthritis Rheum"},{"key":"8286_CR12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0962-8924(02)02371-1","volume":"12","author":"G Meister","year":"2002","unstructured":"Meister G, Eggert C, Fischer U (2002) SMN-mediated assembly of RNPs: a complex story. Trends Cell Biol 12:472\u2013478","journal-title":"Trends Cell Biol"},{"key":"8286_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0955-0674(02)00332-0","volume":"14","author":"S Paushkin","year":"2002","unstructured":"Paushkin S, Gubitz AK, Massenet S, Dreyfuss G (2002) The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol 14:305\u2013312","journal-title":"Curr Opin Cell Biol"},{"key":"8286_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.genom.9.081307.164204","volume":"9","author":"A Antonellis","year":"2008","unstructured":"Antonellis A, Green ED (2008) The role of aminoacyl\u2013tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 9:87\u2013107","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"8286_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tins.2009.11.001","volume":"33","author":"WW Motley","year":"2010","unstructured":"Motley WW, Talbot K, Fischbeck KH (2010) GARS axonopathy: not every neuron\u2019s cup of tRNA. Trends Neurosci 33:59\u201366","journal-title":"Trends Neurosci"},{"key":"8286_CR16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-857X(02)00032-7","volume":"28","author":"IN Targoff","year":"2002","unstructured":"Targoff IN (2002) Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 28:859\u2013890, viii","journal-title":"Rheum Dis Clin North Am"},{"key":"8286_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10165-009-0155-3","volume":"19","author":"M Satoh","year":"2009","unstructured":"Satoh M, Vazquez-Del Mercado M, Chan EK (2009) Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 19:219\u2013228","journal-title":"Mod Rheumatol"},{"key":"8286_CR18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/BOR.0b013e328331638a","volume":"21","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2009) Pathogenic mechanisms of disease in myositis: autoantigens as clues. Curr Opin Rheumatol 21:604\u2013609","journal-title":"Curr Opin Rheumatol"},{"key":"8286_CR19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 48:607\u2013612","journal-title":"Rheumatology (Oxford)"},{"key":"8286_CR20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/ijr.10.48","volume":"5","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Mimori T (2010) Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. Int J Clin Rheumatol 5:523\u2013536","journal-title":"Int J Clin Rheumatol"},{"key":"8286_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"ZE Betteridge","year":"2011","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2011) Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 13:209","journal-title":"Arthritis Res Ther"},{"key":"8286_CR22","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.4049\/jimmunol.158.10.5017","volume":"158","author":"M Satoh","year":"1997","unstructured":"Satoh M, Richards HB, Hamilton KJ, Reeves WH (1997) Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins. J Immunol 158:5017\u20135025","journal-title":"J Immunol"},{"key":"8286_CR23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-2249.1996.d01-775.x","volume":"105","author":"M Satoh","year":"1996","unstructured":"Satoh M, Ajmani AK, Stojanov L, Langdon JJ, Ogasawara T, Wang J, Dooley MA, Richards HB, Winfield JB, Carter TH et al (1996) Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA dependent protein kinase catalytic subunit. Clin Exp Immunol 105:460\u2013467","journal-title":"Clin Exp Immunol"},{"key":"8286_CR24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/MCB.25.2.602-611.2005","volume":"25","author":"TJ Golembe","year":"2005","unstructured":"Golembe TJ, Yong J, Battle DJ, Feng W, Wan L, Dreyfuss G (2005) Lymphotropic Herpesvirus saimiri uses the SMN complex to assemble Sm cores on its small RNAs. Mol Cell Biol 25:602\u2013611","journal-title":"Mol Cell Biol"},{"key":"8286_CR25","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH (2008) Spinal muscular atrophy. Lancet 371:2120\u20132133","journal-title":"Lancet"},{"key":"8286_CR26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/WCO.0b013e32833e1765","volume":"23","author":"CD Wee","year":"2010","unstructured":"Wee CD, Kong L, Sumner CJ (2010) The genetics of spinal muscular atrophies. Curr Opin Neurol 23:450\u2013458","journal-title":"Curr Opin Neurol"},{"key":"8286_CR27","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","volume":"19","author":"C Lagier-Tourenne","year":"2010","unstructured":"Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46\u2013R64","journal-title":"Hum Mol Genet"},{"key":"8286_CR28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10048-010-0239-4","volume":"11","author":"M Blitterswijk van","year":"2010","unstructured":"van Blitterswijk M, Landers JE (2010) RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics 11:275\u2013290","journal-title":"Neurogenetics"},{"key":"8286_CR29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/WCO.0b013e32832ffbe3","volume":"22","author":"P Damme Van","year":"2009","unstructured":"Van Damme P, Robberecht W (2009) Recent advances in motor neuron disease. Curr Opin Neurol 22:486\u2013492","journal-title":"Curr Opin Neurol"},{"key":"8286_CR30","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","volume":"136","author":"C Lagier-Tourenne","year":"2009","unstructured":"Lagier-Tourenne C, Cleveland DW (2009) Rethinking ALS: the FUS about TDP-43. Cell 136:1001\u20131004","journal-title":"Cell"},{"key":"8286_CR31","doi-asserted-by":"crossref","unstructured":"Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS\/TLS in ALS and beyond. Curr Opin Neurobiol (in press)","DOI":"10.1016\/j.conb.2011.05.029"},{"key":"8286_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","volume":"40","author":"M Salajegheh","year":"2009","unstructured":"Salajegheh M, Pinkus JL, Taylor JP, Amato AA, Nazareno R, Baloh RH, Greenberg SA (2009) Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40:19\u201331","journal-title":"Muscle Nerve"},{"key":"8286_CR33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/WCO.0b013e32833d3897","volume":"23","author":"CC Weihl","year":"2010","unstructured":"Weihl CC, Pestronk A (2010) Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers. Curr Opin Neurol 23:482\u2013488","journal-title":"Curr Opin Neurol"},{"key":"8286_CR34","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tcb.2004.03.010","volume":"14","author":"J Yong","year":"2004","unstructured":"Yong J, Wan L, Dreyfuss G (2004) Why do cells need an assembly machine for RNA\u2013protein complexes? Trends Cell Biol 14:226\u2013232","journal-title":"Trends Cell Biol"},{"key":"8286_CR35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mcn.2010.11.006","volume":"46","author":"M Stum","year":"2011","unstructured":"Stum M, McLaughlin HM, Kleinbrink EL, Miers KE, Ackerman SL, Seburn KL, Antonellis A, Burgess RW (2011) An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol Cell Neurosci 46:432\u2013443","journal-title":"Mol Cell Neurosci"},{"key":"8286_CR36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2006.08.027","volume":"51","author":"KL Seburn","year":"2006","unstructured":"Seburn KL, Nangle LA, Cox GA, Schimmel P, Burgess RW (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot\u2013Marie\u2013Tooth 2D mouse model. Neuron 51:715\u2013726","journal-title":"Neuron"},{"key":"8286_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/dmm.002527","volume":"2","author":"F Achilli","year":"2009","unstructured":"Achilli F, Bros-Facer V, Williams HP, Banks GT, AlQatari M, Chia R, Tucci V, Groves M, Nickols CD, Seburn KL et al (2009) An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot\u2013Marie\u2013Tooth type 2D peripheral neuropathy. Dis Model Mech 2:359\u2013373","journal-title":"Dis Model Mech"},{"key":"8286_CR38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1727","volume":"38","author":"A Jordanova","year":"2006","unstructured":"Jordanova A, Irobi J, Thomas FP, Van Dijck P, Meerschaert K, Dewil M, Dierick I, Jacobs A, De Vriendt E, Guergueltcheva V et al (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot\u2013Marie\u2013Tooth neuropathy. Nat Genet 38:197\u2013202","journal-title":"Nat Genet"},{"key":"8286_CR39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ng2013","volume":"39","author":"GC Scheper","year":"2007","unstructured":"Scheper GC, van der Klok T, van Andel RJ, van Berkel CG, Sissler M, Smet J, Muravina TI, Serkov SV, Uziel G, Bugiani M et al (2007) Mitochondrial aspartyl\u2013tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534\u2013539","journal-title":"Nat Genet"},{"key":"8286_CR40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajhg.2010.06.001","volume":"87","author":"LG Riley","year":"2010","unstructured":"Riley LG, Cooper S, Hickey P, Rudinger-Thirion J, McKenzie M, Compton A, Lim SC, Thorburn D, Ryan MT, Giege R et al (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia\u2014MLASA syndrome. Am J Hum Genet 87:52\u201359","journal-title":"Am J Hum Genet"},{"key":"8286_CR41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature05096","volume":"443","author":"JW Lee","year":"2006","unstructured":"Lee JW, Beebe K, Nangle LA, Jang J, Longo-Guess CM, Cook SA, Davisson MT, Sundberg JP, Schimmel P, Ackerman SL (2006) Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443:50\u201355","journal-title":"Nature"},{"key":"8286_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7:327\u2013340","journal-title":"Lancet Neurol"},{"key":"8286_CR43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0030-1255223","volume":"30","author":"MR Rosenfeld","year":"2010","unstructured":"Rosenfeld MR, Dalmau J (2010) Update on paraneoplastic and autoimmune disorders of the central nervous system. Semin Neurol 30:320\u2013331","journal-title":"Semin Neurol"},{"key":"8286_CR44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","volume":"257","author":"F Graus","year":"2010","unstructured":"Graus F, Saiz A, Dalmau J (2010) Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509\u2013517","journal-title":"J Neurol"},{"key":"8286_CR45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1050-1738(03)00075-6","volume":"13","author":"K Musunuru","year":"2003","unstructured":"Musunuru K (2003) Cell-specific RNA-binding proteins in human disease. Trends Cardiovasc Med 13:188\u2013195","journal-title":"Trends Cardiovasc Med"},{"key":"8286_CR46","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","volume":"16","author":"RJ Buckanovich","year":"1996","unstructured":"Buckanovich RJ, Yang YY, Darnell RB (1996) The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 16:1114\u20131122","journal-title":"J Neurosci"},{"key":"8286_CR47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/CCO.0b013e3283306647","volume":"21","author":"A Didelot","year":"2009","unstructured":"Didelot A, Honnorat J (2009) Update on paraneoplastic neurological syndromes. Curr Opin Oncol 21:566\u2013572","journal-title":"Curr Opin Oncol"},{"key":"8286_CR48","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/brain\/awq253","volume":"133","author":"C Geis","year":"2010","unstructured":"Geis C, Weishaupt A, Hallermann S, Grunewald B, Wessig C, Wultsch T, Reif A, Byts N, Beck M, Jablonka S et al (2010) Stiff person syndrome-associated autoantibodies to amphiphysin mediate reduced GABAergic inhibition. Brain 133:3166\u20133180","journal-title":"Brain"},{"key":"8286_CR49","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1091\/mbc.01-11-0544","volume":"13","author":"T Eystathioy","year":"2002","unstructured":"Eystathioy T, Chan EK, Tenenbaum SA, Keene JD, Griffith K, Fritzler MJ (2002) A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 13:1338\u20131351","journal-title":"Mol Biol Cell"},{"key":"8286_CR50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2007.07.016","volume":"125","author":"RA Bhanji","year":"2007","unstructured":"Bhanji RA, Eystathioy T, Chan EK, Bloch DB, Fritzler MJ (2007) Clinical and serological features of patients with autoantibodies to GW\/P bodies. Clin Immunol 125:247\u2013256","journal-title":"Clin Immunol"},{"key":"8286_CR51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/271067a0","volume":"271","author":"D Alarcon-Segovia","year":"1978","unstructured":"Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E (1978) Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271:67\u201369","journal-title":"Nature"},{"key":"8286_CR52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1191\/096120301669579565","volume":"10","author":"D Alarcon-Segovia","year":"2001","unstructured":"Alarcon-Segovia D (2001) Antinuclear antibodies: to penetrate or not to penetrate, that was the question. Lupus 10:315\u2013318","journal-title":"Lupus"},{"key":"8286_CR53","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1084\/jem.20080462","volume":"205","author":"PY Lee","year":"2008","unstructured":"Lee PY, Kumagai Y, Li Y, Takeuchi O, Yoshida H, Weinstein J, Kellner ES, Nacionales D, Barker T, Kelly-Scumpia K et al (2008) TLR7-dependent and Fc{gamma}R-independent production of type I interferon in experimental mouse lupus. J Exp Med 205:2995\u20133006","journal-title":"J Exp Med"},{"key":"8286_CR54","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI14451","volume":"108","author":"EM Tan","year":"2001","unstructured":"Tan EM (2001) Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 108:1411\u20131415","journal-title":"J Clin Invest"},{"key":"8286_CR55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/ard.60.5.433","volume":"60","author":"M Abu-Shakra","year":"2001","unstructured":"Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y (2001) Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 60:433\u2013441","journal-title":"Ann Rheum Dis"},{"key":"8286_CR56","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","volume":"58","author":"M Reuschenbach","year":"2009","unstructured":"Reuschenbach M, von Knebel DM, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535\u20131544","journal-title":"Cancer Immunol Immunother"},{"key":"8286_CR57","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O\u2019Hanlon TP, Miller FW, Rider LG (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 54:3682\u20133689","journal-title":"Arthritis Rheum"},{"key":"8286_CR58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kel161","volume":"46","author":"K Kaji","year":"2007","unstructured":"Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K, Matsushita T, Orito H, Hamaguchi Y, Yanaba K et al (2007) Identification of a novel autoantibody reactive with 155 and 140\u00a0kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 46:25\u201328","journal-title":"Rheumatology (Oxford)"},{"key":"8286_CR59","doi-asserted-by":"crossref","unstructured":"Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, Davidson JE, Cooper RG, McHugh NJ (2008) Clinical associations of autoantibodies to a p155\/140\u00a0kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford)","DOI":"10.1093\/rheumatology\/kem359"},{"key":"8286_CR60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Araguas","year":"2010","unstructured":"Trallero-Araguas E, Labrador-Horrillo M, Selva-O\u2019Callaghan A, Martinez MA, Martinez-Gomez X, Palou E, Rodriguez-Sanchez JL, Vilardell-Tarres M (2010) Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) 89:47\u201352","journal-title":"Medicine (Baltimore)"},{"key":"8286_CR61","doi-asserted-by":"crossref","first-page":"e1000575","DOI":"10.1371\/journal.pgen.1000575","volume":"5","author":"DF Vincent","year":"2009","unstructured":"Vincent DF, Yan KP, Treilleux I, Gay F, Arfi V, Kaniewski B, Marie JC, Lepinasse F, Martel S, Goddard-Leon S et al (2009) Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genet 5:e1000575","journal-title":"PLoS Genet"},{"key":"8286_CR62","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.1101544108","volume":"108","author":"B Herquel","year":"2011","unstructured":"Herquel B, Ouararhni K, Khetchoumian K, Ignat M, Teletin M, Mark M, Bechade G, Van Dorsselaer A, Sanglier-Cianferani S, Hamiche A et al (2011) Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma. Proc Natl Acad Sci U S A 108:8212\u20138217","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8286_CR63","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1172\/JCI45213","volume":"121","author":"R Aucagne","year":"2011","unstructured":"Aucagne R, Droin N, Paggetti J, Lagrange B, Largeot A, Hammann A, Bataille A, Martin L, Yan KP, Fenaux P et al (2011) Transcription intermediary factor 1gamma is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J Clin Invest 121:2361\u20132370","journal-title":"J Clin Invest"},{"key":"8286_CR64","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/j.2326-5205.1989.tb00026.x","volume":"32","author":"EM Tan","year":"1989","unstructured":"Tan EM (1989) Do autoantibodies inhibit function of their cognate antigens in vivo? Arthritis Rheum 32:924\u2013925","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8286-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-011-8286-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-011-8286-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T03:15:27Z","timestamp":1686453327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-011-8286-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,15]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["8286"],"URL":"https:\/\/doi.org\/10.1007\/s12016-011-8286-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,15]]}}}